Multi-institutional retrospective study on chemotherapy and pelvic radiotherapy for stage IVB cervical cancer.
Not Applicable
- Conditions
- Stage IVB cervical cancer
- Registration Number
- JPRN-UMIN000052234
- Lead Sponsor
- Japanese Gynecologic Oncology Group (JGOG) Japanese Radiation Oncology Study Group (JROSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who refused data registration. 2) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 3) Patients who received surgery on the primary tumor during the course of treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Progression-free survival, rate of urinary tract and gastrointestinal tract adverse events (CTCAE Ver 5.0 Grade 3 or higher), rate of genital bleeding requiring blood transfusion